Oestrogen receptor β in breast cancer: good, bad or still too early to tell?SPEIRS, Valerie.Journal of pathology. 2002, Vol 197, Num 2, pp 143-147, issn 0022-3417Article

Not just for women : BREAST CANCERSPEIRS, Valerie.Nature (London). 2012, Vol 485, Num 7400, issn 0028-0836, p. S66Article

Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissuesPOOLA, Indra; SPEIRS, Valerie.Journal of steroid biochemistry and molecular biology. 2001, Vol 78, Num 5, pp 459-469, issn 0960-0760Article

Differential response to phytoestrogens in endocrine sensitive and resistant breast cancer cells in vitroLIMER, Jane L; PARKES, Alicia T; SPEIRS, Valerie et al.International journal of cancer. 2006, Vol 119, Num 3, pp 515-521, issn 0020-7136, 7 p.Article

Phosphorylation of Estrogen Receptor β at Serine 105 Is Associated with Good Prognosis in Breast CancerHAMILTON-BURKE, Werbena; COLEMAN, Louise; SMITH, Laura et al.The American journal of pathology. 2010, Vol 177, Num 3, pp 1079-1086, issn 0002-9440, 8 p.Article

Reduced expression of oestrogen receptor β in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line modelSKLIRIS, George P; MUNOT, Kailas; SPEIRS, Valerie et al.Journal of pathology. 2003, Vol 201, Num 2, pp 213-220, issn 0022-3417, 8 p.Article

Towards a-scan imaging via Ultrasonic Vibration Potential measurementsPENG GUAN; MI WANG; INAKI SCHLABERG, H et al.Nuclear engineering and design. 2011, Vol 241, Num 6, pp 1994-1997, issn 0029-5493, 4 p.Conference Paper

Pattern of expression of genes linked to epigenetic silencing in human breast cancerMUNOT, Kailas; BELL, Sandra M; LANE, Sally et al.Human pathology. 2006, Vol 37, Num 8, pp 989-999, issn 0046-8177, 11 p.Article

Clinical and functional significance of loss of caveolin―1 expression in breast cancer―associated fibroblastsSIMPKINS, Samantha A; HANBY, Andrew M; HOLLIDAY, Deborah L et al.Journal of pathology (Print). 2012, Vol 227, Num 4, pp 490-498, issn 0022-3417, 9 p.Article

Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast CancerROYLANCE, Rebecca; ENDESFELDER, David; EKLUND, Aron C et al.Cancer epidemiology, biomarkers & prevention. 2011, Vol 20, Num 10, pp 2183-2194, issn 1055-9965, 12 p.Article

Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination TrialDOWSETT, Mitch; ALLRED, Craig; BISHOP, Hugh et al.Journal of clinical oncology. 2008, Vol 26, Num 7, pp 1059-1065, issn 0732-183X, 7 p.Article

Microcephalin is a new novel prognostic indicator in breast cancer associated with BRCA1 inactivationRICHARDSON, Julie; SHAABAN, Abeer M; KAMAL, Mohamed et al.Breast cancer research and treatment. 2011, Vol 127, Num 3, pp 639-648, issn 0167-6806, 10 p.Article

Nuclear and Cytoplasmic Expression of ERβ1, ERβ2, and ERβ5 Identifies Distinct Prognostic Outcome for Breast Cancer PatientsSHAABAN, Abeer M; GREEN, Andrew R; GROOME, Nigel P et al.Clinical cancer research (Print). 2008, Vol 14, Num 16, pp 5228-5235, issn 1078-0432, 8 p.Article

A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERβ in archival formalin-fixed paraffin embedded human breast tissueCARDER, Pauline J; MURPHY, Claire E; WALKER, Rosemary A et al.Breast cancer research and treatment. 2005, Vol 92, Num 3, pp 287-293, issn 0167-6806, 7 p.Article

Promoter switch: a novel mechanism causing biallelic PEG1/MEST expression in invasive breast cancerPEDERSEN, Inge Søkilde; DERVAN, Peter; MCGOLDRICK, Alo et al.Human molecular genetics (Print). 2002, Vol 11, Num 12, pp 1449-1453, issn 0964-6906Article

Intracellular flow cytometric analysis of primary cultured breast tumor cellsLOVEDAY, Ruth L; SPEIRS, Valerie; DREW, Philip J et al.Cancer investigation. 2002, Vol 20, Num 3, pp 340-347, issn 0735-7907Article

Genetic events during the transformation of a tamoxifen-sensitive human breast cancer cell line into a drug-resistant cloneACHUTHAN, Rajgopal; BELL, Sandra M; ROBERTS, Paul et al.Cancer genetics and cytogenetics. 2001, Vol 130, Num 2, pp 166-172, issn 0165-4608Article

A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differencesSHAABAN, Abeer M; BALL, Graham R; KANTHAN, Rani et al.Breast cancer research and treatment. 2012, Vol 133, Num 3, pp 949-958, issn 0167-6806, 10 p.Article

CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid-specific cancer cell death through autophagy inductionLEE, Alvin J. X; ROYLANCE, Rebecca; OBEID, Lina M et al.Journal of pathology (Print). 2012, Vol 226, Num 3, pp 482-494, issn 0022-3417, 13 p.Article

ERβ1 Represses FOXM1 Expression through Targeting ERα to Control Cell Proliferation in Breast CancerHORIMOTO, Yoshiya; HARTMAN, Johan; SPEIRS, Valerie et al.The American journal of pathology. 2011, Vol 179, Num 3, pp 1148-1156, issn 0002-9440, 9 p.Article

Estrogen Receptor β1 Expression Is Regulated by miR-92 in Breast CancerAL-NAKHLE, Hakeemah; BURNS, Philip A; CUMMINGS, Michele et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 11, pp 4778-4784, issn 0008-5472, 7 p.Article

Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinomaKAMAL, Mohamed; SHAABAN, Abeer M; LIQUN ZHANG et al.Breast cancer research and treatment. 2010, Vol 121, Num 3, pp 555-563, issn 0167-6806, 9 p.Article

Carcinoembryonic Antigen Cell Adhesion Molecule 6 Predicts Breast Cancer Recurrence following AdjuvantTamoxifenMARAQA, Loaie; CUMMINGS, Michele; PETER, Mark B et al.Clinical cancer research. 2008, Vol 14, Num 2, pp 405-411, issn 1078-0432, 7 p.Article